Mankind Pharma reports 21% fall in Q2 consolidated net profit

07 Nov 2025 Evaluate

Mankind Pharma has reported result for second quarter ended September 30, 2025 (Q2FY26). 

The company has reported 28.89% decline in its net profit at Rs 458.90 crore for the quarter ended September 30, 2025 as compared to Rs 645.34 crore for the same quarter in the previous year. However, total income of the company increased marginally by 1.31% at Rs 2,686.45 crore for Q2FY26 as compared to Rs 2,651.66 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 21.05% decline in its net profit at Rs 520.18 crore for Q2FY26 as compared to Rs 658.88 crore for the same quarter in the previous year. However, the total income of the company increased by 19.51% at Rs 3,789.03 crore for Q2FY26 as compared to Rs 3,170.49 crore for the corresponding quarter previous year.

Mankind Pharma Share Price

2176.15 -67.75 (-3.02%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×